Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

UBQLN4 Is a Prognostic Biomarker in Intrahepatic Cholangiocarcinoma That Is Associated with Cisplatin Resistance

Elevated UBQLN4 expression is associated with adverse clinical outcomes and reduced response to cisplatin-containing chemotherapy in iCCA, while functional studies support a potential role for UBQLN4 in modulating cisplatin sensitivity.

Kodai Abe, Kelly Chong, Y. Abe et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.